The Measurement Technology in Downstream Processing Market is projected to grow from USD 5.0 billion in 2022 to an estimated USD 7.2 billion by 2028, according to a recent survey by Future Market Insights. This growth, driven by the increasing prevalence of chronic illnesses such as cardiovascular diseases, cancers, and diabetes, highlights the pivotal role of downstream processing in biopharmaceutical production.
Key Drivers: Biologics and Purification Technologies
The rising demand for biologics, recognized for their superior efficacy and fewer side effects compared to traditional small molecule drugs, is fueling advancements in downstream processing technologies. As global healthcare systems prioritize precision medicine, the need for purified biopharmaceutical products is surging. Purification of modified therapeutic products has emerged as a critical factor in ensuring the efficacy and safety of biologics, further boosting market demand.
Market Trends and Technological Advancements
Innovations in measurement technology are streamlining downstream processing, enhancing efficiency, and reducing production timelines. Industry stakeholders are focusing on automated and real-time monitoring solutions to optimize biopharmaceutical purification. These advancements are expected to facilitate large-scale biologics production, catering to the growing global healthcare needs.
A Detailed Full Report – https://www.futuremarketinsights.com/reports/measurement-technology-in-downstream-processing-market
Key Takeaways
- The Measurement Technology in Downstream Processing Market is set to grow at a significant rate, reaching USD 7.2 billion by 2028, up from USD 5.0 billion in 2022.
- The rising prevalence of chronic illnesses and demand for biologics drive market growth.
- Advances in purification technologies are crucial to producing safer and more effective biopharmaceuticals.
- Industry focus on automation and real-time monitoring solutions enhances downstream processing efficiency.
The growth of the downstream processing market underscores its essential role in meeting the global demand for biologics, offering safer therapeutic options, and advancing healthcare innovation worldwide.
Growth Drivers
- Increasing Prevalence of Chronic Illnesses: The rising incidence of chronic diseases, particularly cardiovascular diseases, cancers, and diabetes, is driving investments in the biologics market. This trend boosts the demand for effective measurement technologies in biopharmaceutical production.
- Demand for Biologics: Biologics are preferred due to their higher efficacy and fewer side effects compared to traditional small molecule drugs. This preference leads to an increased focus on the purification processes of modified therapeutic products, further driving demand for measurement technologies.
- Advancements in Measurement Technology: Continuous innovations in sensor technologies and bioprocess control equipment enhance the efficiency and accuracy of downstream processing, making them essential for modern biopharmaceutical manufacturing.
- Regulatory Requirements: Stringent regulatory standards necessitate precise measurement and monitoring during bioprocessing to ensure product quality and compliance, thereby increasing the demand for advanced measurement solutions.
- Shift Towards Single-Use Technologies: The growing adoption of single-use systems in bioprocessing reduces the risk of cross-contamination and simplifies cleaning processes, leading to increased demand for single-use measurement technologies.
- Investment in R&D: Pharmaceutical and biotechnology companies are investing heavily in research and development to innovate new products and improve existing processes, which drives the need for advanced measurement technologies.
Regional Insights
- North America is expected to hold a significant share of the market due to its established pharmaceutical industry and high investment in biopharmaceutical research.
- The Asia-Pacific region is projected to experience rapid growth driven by increasing investments in healthcare infrastructure and a growing number of contract manufacturing organizations.
Competitive Landscape
Companies operating in the measurement technology in downstream processing market devices are actively seeking to strengthen their position through expansion, and merger & acquisition, with established as well as emerging market players.
Some of the recent instances include:
- In April 2021, Thermo Fisher Scientific Acquired PPD, Inc., a Leading Clinical Research Organization to Further expands service offering to pharma and biotech customers.
- In 2021, Sartorius strengthens its product portfolio with respect to cell and gene therapy by acquiring a key stake in CellGenix.
Key Companies Profiled
Applikon Biotechnology Inc.; Sartorius AG; Broadley-James Corporation; Thermo Fisher Scientific Inc.; Hamilton Company; Waters Corporation; PreSens Precision Sensing GmbH; PendoTECH LLC; Endress+Hauser AG; Mettler-Toledo International Inc.; Metroglas AG; Madison; YSI; Evoqua; Sensorex; Forbes
Measurement technology in downstream processing market by Category
By Product:
- Sensors
- pH Sensors
- Optical
- Electrochemical
- DO Sensors
- Optical
- Eelctrochemical
- Conductivity Sensors
- Cell Density Sensors
- pH Sensors
- Sensor Housings
- Transmitters & Controllers
- Cables & Connectors
- Buffers & Reagents
By Modality:
- Single-use
- Reusable
By End User:
- Pharmaceutical & Biotechnology Companies
- Food & Beverage Companies
- Contract Manufacturing Organizations
- Academic & Research Institutes
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia-Pacific excluding Japan
- Japan
- Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube